| Financial Year |
March 31 2023 |
| Monetary Funds |
347,956,437.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
8,117,988.59 |
| Advances to Suppliers |
8,355,715.90 |
| Other Receivables |
2,462,451.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,851,353.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,728,687.19 |
| Total Current Assets |
374,472,634.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,018,074.82 |
| Investment Properties |
26,531,206.80 |
| Fixed Assetes |
940,937,599.52 |
| Under-construction Projects |
6,599,443.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
104,372,777.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,647,955.44 |
| Deferred Income Tax Assets |
21,590,941.59 |
| Other Non-Current Assets |
33,416,613.05 |
| Sub-Total of Non-Current Assets |
1,217,229,611.45 |
| Total Assets |
1,591,702,246.06 |
| Short-Term Loans |
80,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,200,000.00 |
| Accounts Payable |
46,221,159.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,649,854.34 |
| Taxes Payable |
13,346,847.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,074,440.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,417,425.22 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
192,423,096.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,100,715.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,278,749.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
95,317,099.60 |
| Total Liabilities |
287,740,195.85 |
| Paid-In Capital(Or Share Stock) |
186,294,283.00 |
| Capital Surplus |
543,095,375.38 |
| Surplus Reserve |
59,819,869.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
409,801,670.27 |
| Minority Stockholder's Interest |
97,121,279.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,206,840,770.89 |
| Owner's Equity（Stockholder's Equity） |
1,303,962,050.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,591,702,246.06 |
